Mental Healthcare in Older Adults With Schizophrenia
CSA
The Mortality and Its Associated Factors in Schizophrenia Patients Older Than 60 Years
1 other identifier
observational
685
1 country
1
Brief Summary
As in the general population, there is a gradual and steady increase in life expectancy of patients with schizophrenia. But this increase is at a smaller scale, with a rate of premature death that is still 2 to 3 times higher than that found in the general population. This excessive early mortality is explained by an overrepresentation of suicide deaths, but also a higher prevalence of somatic diseases, mainly cardiovascular. But today there are only very few epidemiological data on the mortality of patients with schizophrenia, including those aged over 60 years. What are the sociodemographic and clinical characteristics (psychiatric and somatic) of these schizophrenic elderly patients? Do they benefit from a somatic follow-up adequate and systematic? What are their levels of social independence and of quality of life? the answers these questions and the description of the offer of geriatric care and of psychiatric care currently provided by different sectors of psychiatry in France is an indispensable prerequisite for any project to improve the quality of life, state of health and mortality of older patients with schizophrenia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2010
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2010
CompletedFirst Submitted
Initial submission to the registry
August 26, 2016
CompletedFirst Posted
Study publicly available on registry
August 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2018
CompletedSeptember 2, 2016
September 1, 2016
8.5 years
August 26, 2016
September 1, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Death
Death of any causes
5 years
Study Arms (2)
schizophrenia
chronic psychiatric disorder other than schizophrenia
Interventions
Eligibility Criteria
Patients with schizophrenia and patients with chronic psychiatric disorder other than schizophrenia were included
You may qualify if:
- Men or women aged than 60 years with a diagnosis of schizophrenia, according to the DSM-IV criteria
- Men or women aged than 60 years with chronic psychiatric disorder other than schizophrenia
- Patients consenting to participate to the study
- Patients enrolled in the national healthcare insurance program
You may not qualify if:
- Disease affecting the central nervous system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Chu de Reims
Reims, France, 51092, France
Related Publications (1)
Raucher-Chene D, Hoertel N, Bera-Potelle C, Terrien S, Barriere S, Da Rin D, Tran E, Cuervo-Lombard C, Portefaix C, Limosin F. Mental healthcare in older adults with schizophrenia: results from 118 French public psychiatric departments. Int Psychogeriatr. 2015 Oct;27(10):1749-50. doi: 10.1017/S1041610215001064. Epub 2015 Jul 6. No abstract available.
PMID: 26144544BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2016
First Posted
August 31, 2016
Study Start
January 1, 2010
Primary Completion
July 1, 2018
Study Completion
July 1, 2018
Last Updated
September 2, 2016
Record last verified: 2016-09